Targeting JAK/STAT signaling pathways in treatment of inflammatory bowel disease

Inflamm Res. 2021 Jul;70(7):753-764. doi: 10.1007/s00011-021-01482-x. Epub 2021 Jul 1.

Abstract

Janus kinase/signal transduction and transcriptional activator (JAK/STAT) signaling pathway is a transport hub for cytokine secretion and exerts its effects. The activation of JAK/STAT signaling pathway is essential for the regulation of inflammatory responses. Inappropriate activation or deletion of JAK/STAT signaling pathway is the initiator of the inflammatory response. JAK/STAT signaling pathway has been demonstrated to be involved in the process of innate and adaptive immune response to inflammatory bowel disease (IBD). In this review, we discuss the role of the JAK/STAT signaling pathway in the regulation of different cells in IBD, as well as new findings on the involvement of the JAK/STAT signaling pathway in the regulation of the intestinal immune response. The current status of JAK inhibitors in the treatment of IBD is summarized as well. This review highlights natural remedies that can serve as potential JAK inhibitors. These phytochemicals may be useful in the identification of precursor compounds in the process of designing and developing novel JAK inhibitors.

Keywords: Cytokine; Inflammatory bowel disease; Intestinal inflammation; JAK inhibitor; JAK/STAT; Traditional Chinese medicine.

Publication types

  • Review

MeSH terms

  • Animals
  • Biological Products / therapeutic use
  • Humans
  • Inflammatory Bowel Diseases / drug therapy*
  • Inflammatory Bowel Diseases / metabolism
  • Janus Kinase Inhibitors / pharmacology
  • Janus Kinase Inhibitors / therapeutic use*
  • Janus Kinases / antagonists & inhibitors
  • Janus Kinases / metabolism*
  • STAT Transcription Factors / antagonists & inhibitors
  • STAT Transcription Factors / metabolism*
  • Signal Transduction / drug effects

Substances

  • Biological Products
  • Janus Kinase Inhibitors
  • STAT Transcription Factors
  • Janus Kinases